These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22623003)

  • 1. Coronary artery stenting in a patient with factor XI deficiency.
    Kaku B; Shimojima M; Yoshida T; Katsuda S; Taguchi T; Nitta Y; Sugimori C; Hiraiwa Y
    Cardiovasc Interv Ther; 2012 May; 27(2):99-104. PubMed ID: 22623003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention in a patient with factor XI deficiency.
    Shimony A; Levi E; Zahger D
    J Invasive Cardiol; 2009 Sep; 21(9):E178-9. PubMed ID: 19726832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
    Stone GW; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Gurbel PA; Xu K; Parise H; Kirtane AJ; Brodie BR; Mehran R; Stuckey TD;
    Lancet; 2013 Aug; 382(9892):614-23. PubMed ID: 23890998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-TRIPLE) study.
    Fiedler KA; Byrne RA; Schulz S; Sibbing D; Mehilli J; Ibrahim T; Maeng M; Laugwitz KL; Kastrati A; Sarafoff N
    Am Heart J; 2014 Apr; 167(4):459-465.e1. PubMed ID: 24655693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
    Baber U; Akhter M; Kothari S; Sharma SK; Kini A
    J Invasive Cardiol; 2010 Feb; 22(2):80-3. PubMed ID: 20124594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term successful percutaneous coronary intervention in factor VII deficiency.
    Linares Vicente JA; Pérez JO; Lacasa RC
    J Invasive Cardiol; 2012 Jun; 24(6):E119-21. PubMed ID: 22684392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
    Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single antiplatelet therapy after percutaneous coronary intervention in patients allergic to aspirin.
    Agarwal SK
    Cardiovasc Revasc Med; 2014; 15(5):308-10. PubMed ID: 24880912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial.
    Collet JP; Silvain J; Barthélémy O; Rangé G; Cayla G; Van Belle E; Cuisset T; Elhadad S; Schiele F; Lhoest N; Ohlmann P; Carrié D; Rousseau H; Aubry P; Monségu J; Sabouret P; O'Connor SA; Abtan J; Kerneis M; Saint-Etienne C; Beygui F; Vicaut E; Montalescot G;
    Lancet; 2014 Nov; 384(9954):1577-85. PubMed ID: 25037988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stents.
    Kang SJ; Mintz GS; Witzenbichler B; Metzger DC; Rinaldi MJ; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Shimizu T; Xu K; Kirtane AJ; Stone GW; Maehara A
    Circ Cardiovasc Interv; 2015 Jan; 8(1):. PubMed ID: 25552564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraprocedural thrombus formation in the left main tract during primary percutaneous coronary intervention.
    Oh JH; Lee HC; Cha KS
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S163-5. PubMed ID: 25518758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary artery bypass grafting for simultaneous subacute stent thrombosis after sirolimus-eluting stent implantation].
    Matsumoto M; Suehiro K; Kubo Y; Onoue G; Komatsubara I; Seito T; Morimoto N; Shiraishi K; Kasai S; Hagioka S; Naito H; Nagae M
    Kyobu Geka; 2008 May; 61(5):355-8. PubMed ID: 18464477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry.
    Nakamura M; Yamagishi M; Ueno T; Hara K; Ishiwata S; Itoh T; Hamanaka I; Wakatsuki T; Sugano T; Kawai K; Kimura T
    Cardiovasc Interv Ther; 2013 Apr; 28(2):162-9. PubMed ID: 23233418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful recanalization of a left circumflex artery jailed with a polytetrafluoroethylene-covered stent after coronary perforation during stent implantation in the left main bifurcation.
    Taniguchi N; Takahashi A; Mizuguchi Y; Yamada T; Hata T; Nakajima S
    Cardiovasc Interv Ther; 2015 Jan; 30(1):78-81. PubMed ID: 24557981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS; Somi S; Roolvink V; Rasoul S; Ottervanger JP; Gosselink AT; Hoorntje JC; Dambrink JH; de Boer MJ; Suryapranata H; van 't Hof AW;
    JACC Cardiovasc Interv; 2014 Jul; 7(7):751-8. PubMed ID: 25060017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.